35% Of This Encompass Health Insider's Holdings Were Sold
35% Of This Encompass Health Insider's Holdings Were Sold
Viewing insider transactions for Encompass Health Corporation's (NYSE:EHC ) over the last year, we see that insiders were net sellers. This means that a larger number of shares were sold by insiders in relation to shares purchased.
查看过去一年内 Encompass Health 公司(NYSE:EHC)的内部交易,我们发现内部人员净卖出。这意味着与购买股份相比,内部人员卖出了更多的股份。
While insider transactions are not the most important thing when it comes to long-term investing, we would consider it foolish to ignore insider transactions altogether.
虽然在长期投资方面内部交易并非最重要的事情,但完全忽略内部交易是愚蠢的。
Encompass Health Insider Transactions Over The Last Year
在过去的一年中,Encompass Health 公司的内部交易
In the last twelve months, the biggest single sale by an insider was when the Chief Medical Officer, Elissa Charbonneau, sold US$850k worth of shares at a price of US$85.02 per share. So it's clear an insider wanted to take some cash off the table, even below the current price of US$98.91. When an insider sells below the current price, it suggests that they considered that lower price to be fair. That makes us wonder what they think of the (higher) recent valuation. While insider selling is not a positive sign, we can't be sure if it does mean insiders think the shares are fully valued, so it's only a weak sign. It is worth noting that this sale was only 35% of Elissa Charbonneau's holding. The only individual insider seller over the last year was Elissa Charbonneau.
在过去十二个月里,最大的一次内部人员卖出是首席医疗官 Elissa Charbonneau 以每股 85.02 美元的价格卖出价值 85万美元的股份。因此,很明显一位内部人员想要提前套现,甚至低于当前价格 98.91 美元。当一位内部人员以低于当前价格卖出时,这意味着他们认为较低的价格是公平的。这让我们想知道他们对(较高的)最近的估值持何看法。虽然内部人员的卖出并不是一个积极信号,但我们不能确定这是否意味着内部人员认为股份被充分定价,因此这只是一个微弱的信号。值得注意的是这笔交易仅占 Elissa Charbonneau 持股的35%。去年唯一一个卖出的个人内部人员是 Elissa Charbonneau。
The chart below shows insider transactions (by companies and individuals) over the last year. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!
下面的图表显示了公司和个人过去一年的内部交易。如果单击图表,您可以查看所有单独的交易,包括股价、个人和日期!
I will like Encompass Health better if I see some big insider buys. While we wait, check out this free list of undervalued and small cap stocks with considerable, recent, insider buying.
如果我看到一些大规模内部买入交易,我会更喜欢 encompass health。在我们等待时,请查看这份免费的低估和小盘股票清单,其中包括近期重要的内部买入交易。
Does Encompass Health Boast High Insider Ownership?
encompass health是否拥有高比例内部持股?
I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. I reckon it's a good sign if insiders own a significant number of shares in the company. It's great to see that Encompass Health insiders own 1.3% of the company, worth about US$128m. I like to see this level of insider ownership, because it increases the chances that management are thinking about the best interests of shareholders.
我喜欢查看公司内部人员持有的股份数量,以帮助形成我对他们与内部人员是否一致看法的观点。如果内部人员持有公司的相当数量股份,这是一个很好的迹象。很高兴看到 encompass health的内部人员拥有公司1.3%的股份,价值约12800万美元。我喜欢看到这种程度的内部持股,因为这增加了管理层考虑股东最大利益的机会。
So What Does This Data Suggest About Encompass Health Insiders?
那这些数据对 encompass health内部人员有何启示?
There haven't been any insider transactions in the last three months -- that doesn't mean much. While we feel good about high insider ownership of Encompass Health, we can't say the same about the selling of shares. So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. You'd be interested to know, that we found 1 warning sign for Encompass Health and we suggest you have a look.
过去三个月内没有任何内部交易,这并不意味着什么。尽管我们对encompass health高比例内部持股持有乐观态度,但我们不能说同样的事情发生在股票的卖出上。因此,这些内部交易可以帮助我们建立关于该股票的观点,但了解该公司面临的风险也是值得的。您很可能会感兴趣,我们为encompass health发现了1个警示迹象,并建议您一探究竟。
Of course Encompass Health may not be the best stock to buy. So you may wish to see this free collection of high quality companies.
当然,包含医疗可能不是最佳的股票买入选择。因此,您可能希望查看这些优质公司的免费合集。
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
对于本文而言,内部人是指向相关监管机构报告其交易的个人。我们目前仅考虑公开市场交易和直接利益的私人处置,但不包括衍生交易或间接利益。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对这篇文章有反馈吗?对内容感到担忧吗?请直接与我们联系。或者,发送电子邮件至editorial-team @ simplywallst.com。
Simply Wall St的这篇文章是一般性质的。我们仅基于历史数据和分析师预测提供评论,使用公正的方法,我们的文章并非意在提供财务建议。这并不构成买入或卖出任何股票的建议,并且不考虑您的目标或财务状况。我们旨在为您带来基于基础数据驱动的长期聚焦分析。请注意,我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St对提及的任何股票都没有持仓。